Literature DB >> 8574825

Nucleotide sequence analysis and seroreactivities of the 65K heat shock protein from Mycobacterium paratuberculosis.

F A el-Zaatari1, S A Naser, L Engstrand, P E Burch, C Y Hachem, D L Whipple, D Y Graham.   

Abstract

Mycobacterium paratuberculosis is the causative agent of Johne's disease, a chronic enteritis in ruminants. It has also been implicated as a possible cause of Crohn's disease, an inflammatory bowel disease of unknown etiology. The mycobacterial 65K heat shock proteins (hsp-65K) are among the most extensively studied mycobacterial proteins, and their immunogenic characteristics have been suggested to be the basis for autoimmunization in chronic inflammatory diseases. In this context, we isolated and sequenced the hsp-65K-encoding gene from our M. paratuberculosis PTB65K genomic library. A high degree of identity was found between the open reading frame (ORF) of the PTB65K gene and those of Mycobacterium tuberculosis (89.6%), Mycobacterium leprae (86.6%), and Mycobacterium avium 18 (98.8%). The amino acid sequence alignment of the PTB65K protein with the hsp-65K homologs revealed that the M. tuberculosis and M. leprae proteins each differed by 36 amino acid residues and that the M. avium 18 protein differed by 8 residues. We also investigated the humoral immune responses of animals with Johne's disease and patients with Crohn's disease against the recombinant PTB65K antigen. Immunoblot analysis showed that sera from only 3 of 10 clinically ill and 5 of 25 subclinically ill cows reacted with PTB65K. In addition, sera from two of two sheep and one of two goats with clinical symptoms of Johne's disease also reacted with PTB65K; 0 samples from 10 normal cows reacted. In humans, sera from 7 of 13 patients with Crohn's disease, 3 of 4 with tuberculosis, 5 of 6 with leprosy, 5 of 12 with non-inflammatory bowel disease, and 0 of 4 with ulcerative colitis reacted with the recombinant PTB65K antigen. These results indicate that this PTB65K heat shock protein is uninformative when used for serodiagnosis of Johne's disease in animals. However, in humans, the high intensity of antibody reactions of some sera from Crohn's disease patients compared with that from noninflammatory bowel disease patients showed a positive correlation with mycobacterial diseases.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8574825      PMCID: PMC170216          DOI: 10.1128/cdli.2.6.657-664.1995

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  46 in total

1.  Cloning of the mycobacterial epitope recognized by T lymphocytes in adjuvant arthritis.

Authors:  W van Eden; J E Thole; R van der Zee; A Noordzij; J D van Embden; E J Hensen; I R Cohen
Journal:  Nature       Date:  1988-01-14       Impact factor: 49.962

2.  The 65-kilodalton antigen of Mycobacterium tuberculosis.

Authors:  T M Shinnick
Journal:  J Bacteriol       Date:  1987-03       Impact factor: 3.490

3.  Enumeration of T cells reactive with Mycobacterium tuberculosis organisms and specific for the recombinant mycobacterial 64-kDa protein.

Authors:  S H Kaufmann; U Väth; J E Thole; J D Van Embden; F Emmrich
Journal:  Eur J Immunol       Date:  1987-03       Impact factor: 5.532

4.  Mycobacteria and inflammatory bowel disease. Results of culture.

Authors:  D Y Graham; D C Markesich; H H Yoshimura
Journal:  Gastroenterology       Date:  1987-02       Impact factor: 22.682

5.  Mycobacterial aetiology of Crohn's disease: serologic study using common mycobacterial antigens and a species-specific glycolipid antigen from Mycobacterium paratuberculosis.

Authors:  S N Cho; P J Brennan; H H Yoshimura; B I Korelitz; D Y Graham
Journal:  Gut       Date:  1986-11       Impact factor: 23.059

6.  Mycobacterium paratuberculosis infection in a colony of stumptail macaques (Macaca arctoides).

Authors:  H M McClure; R J Chiodini; D C Anderson; R B Swenson; W R Thayer; J A Coutu
Journal:  J Infect Dis       Date:  1987-05       Impact factor: 5.226

7.  Characterization, sequence determination, and immunogenicity of a 64-kilodalton protein of Mycobacterium bovis BCG expressed in escherichia coli K-12.

Authors:  J E Thole; W J Keulen; J De Bruyn; A H Kolk; D G Groothuis; L G Berwald; R H Tiesjema; J D van Embden
Journal:  Infect Immun       Date:  1987-06       Impact factor: 3.441

8.  Crohn's disease-isolated mycobacteria are identical to Mycobacterium paratuberculosis, as determined by DNA probes that distinguish between mycobacterial species.

Authors:  J J McFadden; P D Butcher; R Chiodini; J Hermon-Taylor
Journal:  J Clin Microbiol       Date:  1987-05       Impact factor: 5.948

9.  No evidence for antibodies to mycobacterial A60 antigen in Crohn's disease sera by enzyme-linked immunoabsorbent assay (ELISA).

Authors:  J J McFadden; C Houdayer
Journal:  J Med Microbiol       Date:  1988-04       Impact factor: 2.472

10.  Use of recombinant antigens expressed in Escherichia coli K-12 to map B-cell and T-cell epitopes on the immunodominant 65-kilodalton protein of Mycobacterium bovis BCG.

Authors:  J E Thole; W C van Schooten; W J Keulen; P W Hermans; A A Janson; R R de Vries; A H Kolk; J D van Embden
Journal:  Infect Immun       Date:  1988-06       Impact factor: 3.441

View more
  11 in total

Review 1.  Mycobacterium avium subsp. paratuberculosis in Veterinary Medicine.

Authors:  N B Harris; R G Barletta
Journal:  Clin Microbiol Rev       Date:  2001-07       Impact factor: 26.132

2.  Profiling bovine antibody responses to Mycobacterium avium subsp. paratuberculosis infection by using protein arrays.

Authors:  John P Bannantine; Michael L Paustian; W Ray Waters; Judith R Stabel; Mitchell V Palmer; Lingling Li; Vivek Kapur
Journal:  Infect Immun       Date:  2007-11-26       Impact factor: 3.441

3.  Characterization of a specific Mycobacterium paratuberculosis recombinant clone expressing 35,000-molecular-weight antigen and reactivity with sera from animals with clinical and subclinical Johne's disease.

Authors:  F A El-Zaatari; S A Naser; D Y Graham
Journal:  J Clin Microbiol       Date:  1997-07       Impact factor: 5.948

4.  Identification of Mycobacterium avium complex in sarcoidosis.

Authors:  F A el-Zaatari; S A Naser; D C Markesich; D C Kalter; L Engstand; D Y Graham
Journal:  J Clin Microbiol       Date:  1996-09       Impact factor: 5.948

5.  Analysis of culture filtrate and cell wall-associated antigens of Mycobacterium paratuberculosis with monoclonal antibodies.

Authors:  L M Mutharia; W Moreno; M Raymond
Journal:  Infect Immun       Date:  1997-02       Impact factor: 3.441

6.  Protection against Mycobacterium avium by DNA vaccines expressing mycobacterial antigens as fusion proteins with green fluorescent protein.

Authors:  M Velaz-Faircloth; A J Cobb; A L Horstman; S C Henry; R Frothingham
Journal:  Infect Immun       Date:  1999-08       Impact factor: 3.441

7.  Impaired humoral immune response against mycobacterial 65-kDa heat shock protein (HSP65) in patients with inflammatory bowel disease.

Authors:  Laszló Bene; George Füst; Zoltán Huszti; Zsolt Hernádi; Béla Fekete; Márta Mészáros; Amarilla Veres; Agota Kovács; Kata Miklós; Mahavir Singh; László Romics; Zoltán Prohászka
Journal:  Dig Dis Sci       Date:  2002-07       Impact factor: 3.199

8.  Expression and immunogenicity of proteins encoded by sequences specific to Mycobacterium avium subsp. paratuberculosis.

Authors:  John P Bannantine; Janis K Hansen; Michael L Paustian; Alongkorn Amonsin; Ling-Ling Li; Judith R Stabel; Vivek Kapur
Journal:  J Clin Microbiol       Date:  2004-01       Impact factor: 5.948

Review 9.  Epidemiological evidence for Mycobacterium avium subspecies paratuberculosis as a cause of Crohn's disease.

Authors:  J C Uzoigwe; M L Khaitsa; P S Gibbs
Journal:  Epidemiol Infect       Date:  2007-04-20       Impact factor: 2.451

10.  Exploring the role of Mycobacterium avium subspecies paratuberculosis in the pathogenesis of type 1 diabetes mellitus: a pilot study.

Authors:  Saleh A Naser; Saisathya Thanigachalam; C Thomas Dow; Michael T Collins
Journal:  Gut Pathog       Date:  2013-06-13       Impact factor: 4.181

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.